Medication info
Sitaact Tablet 100/30mg (Sitagliptin, Pioglitazone)

Sitaact Tablet 100/30mg (Sitagliptin, Pioglitazone)

Prescription medicationTablet
Ingredient · strength
Sitagliptin Phosphate Hydrate›128.5mg / 1 tabletPioglitazone Hydrochloride›33.06mg / 1 tablet
Manufacturer / importer
Daewoo Pharmaceutical Co., Ltd.
Appearance
Light orange, elongated film-coated tablets
Packaging
28 tablets/box [14 tablets/PTP x 2]
Approval status
Active

MFDS item code 202302261 · Approved 2023.07.28 · Insurance code 649606240

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
This medicine may be administered as 1 tablet once daily, regardless of meals, to patients with type 2 diabetes mellitus receiving concomitant sitagliptin 100mg and pioglitazone 15mg or 30mg. Assessment of renal function is recommended before starting this medicine and periodically thereafter. - No dosage adjustment based on renal function is necessary when the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher. - Do not administer this medicine when the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2.

Ingredients

Manufacturer
Daewoo Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is prescribed to improve blood sugar control in patients with type 2 diabetes as an adjunct to diet and exercise. The combination of sitagliptin and pioglitazone helps effectively improve blood sugar levels, aiding in diabetes management. With consistent use, blood sugar management can be more effective.

Dosage and Administration

Adult dosage

This medicine may be administered as 1 tablet once daily, regardless of meals, to patients with type 2 diabetes mellitus receiving concomitant sitagliptin 100mg and pioglitazone 15mg or 30mg. Assessment of renal function is recommended before starting this medicine and periodically thereafter. - No dosage adjustment based on renal function is necessary when the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher. - Do not administer this medicine when the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2.

Precautions

This medication contains two ingredients used for the treatment of diabetes. The first ingredient helps with blood sugar control but can rarely cause serious side effects such as severe allergic reactions, skin disorders, or pancreatitis; if such symptoms are suspected, use should be discontinued immediately and a doctor consulted. The second ingredient improves insulin resistance and lowers blood sugar, but can exacerbate heart failure symptoms in patients with weak cardiac function; therefore, it should not be used in those with heart disease or a history of heart failure. Additionally, this medication should not be administered to patients with significantly impaired kidney function, severely reduced liver function, bladder cancer patients, pregnant women, or women who may become pregnant. During the medication course, patients should closely monitor for any signs of heart failure such as weight gain, edema, or shortness of breath. Hypoglycemic symptoms may also occur, thus it is essential to manage blood sugar levels carefully. This medication should be used with caution if there are liver function abnormalities or severe kidney dysfunction, particularly in elderly patients over 75 years old, premenopausal women, or patients in poor nutritional status. If sudden joint pain, skin rashes, or blistering skin conditions occur during treatment, it is important to inform a doctor immediately and consider discontinuing the medication. Moreover, this medication may interact with other drugs, so if other medications are being taken, it is essential to inform a doctor or pharmacist and seek advice. Regular blood tests and liver function tests are crucial before and during treatment to check for any abnormalities. Finally, as this medication contains lactose, patients with lactose intolerance should not take it.

Side effects

  • Allergic reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • congestive heart failure
  • fluid retention
  • edema
  • upper respiratory tract infection
  • nasopharyngitis
Show 78 more
  • headache
  • diarrhea
  • abdominal pain
  • nausea
  • constipation
  • vomiting
  • severe arthralgia with disabilities
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • hypoglycemia
  • acute renal failure
  • elevated liver enzymes
  • liver failure
  • vision loss
  • diabetic macular edema
  • worsening of liver disease
  • increased serum triglycerides
  • elevated low-density lipoprotein
  • hyperglycemia
  • dyspepsia
  • dizziness
  • increased serum creatinine
  • anxiety
  • insomnia
  • drowsiness
  • simple herpes
  • blurred vision
  • hypertension
  • cardiac dysfunction
  • orthostatic hypotension
  • palpitations
  • stroke
  • sexual dysfunction
  • myocardial infarction
  • abdominal pain
  • cardiac arrest
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • chest pain
  • fatigue
  • weakness
  • dyspnea
  • itching
  • chest discomfort
  • tremors
  • chills
  • gastrointestinal disease
  • epigastric discomfort
  • numbness
  • muscle rigidity
  • head discomfort
  • urticaria
  • eczema
  • arthralgia
  • knee anomalies
  • arm weakness
  • proteinuria
  • heart failure
  • limb pain
  • low back pain
  • chest pain
  • urinary tract infection
  • elevated serum creatine kinase
  • sinusitis
  • weight gain
  • low back pain
  • dizziness
  • abdominal distension
  • macular edema
  • fracture

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light to pass through. It should also be kept away from humid places, ideally at a cool temperature between 15 to 30 degrees Celsius.

Appearance and packaging

Appearance

Light orange, elongated film-coated tablets

Package unit

28 tablets/box [14 tablets/PTP x 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.